Samuel Gershon Award

This award is named after Dr. Samuel Gershon one of the founding fathers of the Society and an international opinion leader in the field of mood disorders. The Award Committee confers up to four awards per year, including up to 2 to applicants from developed countries and up to 2 to applicants from developing countries. Successful applicants are presented with a commemorative engraved award at the opening ceremony of the Society’s annual meeting, and are required to present their work in a dedicated symposium.  

Eligibility Criteria

  • Early Career researchers or clinicians
    • Up to 2 years post PhD for non-medical applicants
    • Up to 2 years post-residency for medically qualified applicants
  • Submission of a full unpublished manuscript written in English according to the format below
    • Up to 4500 words
    • Structured abstract up to 250 words to include Background, Methods, Results, Conclusions
    • Main text to include Introduction, Methods, Results and Discussion; subheadings within the section are encouraged to promote clarity
    • Up to 100 references; references should be cited using numerals in the main text and listed accordingly in the Reference list
      References should include the names of all authors and should follow the format below:
      Article: Gershon S, Chengappa KN. Lithium: the long road. Bipolar Disord. 2010; 12(7):667-8
      Book: Soares JC, Gershon S. Handbook of Medical Psychiatry. Marcel Dekker, Inc. New York, NY. 2003.
    • Up to 4 tables and up to 4 figures

Additional documentation

  • Personal statement by the applicant regarding their individual contribution to the manuscript submitted, their current career plans and how the award may benefit them.
  • Letter of support by the applicant’s mentor and/or Head of Department where the research was undertaken. The letter should explicitly confirm the criteria for early career eligibility

Application Process

  • Deadline for submission
  • Submitted manuscripts will be reviewed by experts selected by the award committee ; reviews will be considered and the awardees will be selected by the committee; all awards are final
  • Award Notification

The application deadline for 2014 Samuel Gershon Awards has passed. We are no longer accepting applications for 2014 Samuel Gershon Awards.

 

Previous Awardees

2013

 

B.C.M. Haarman, MD, University Medical Center, Groningen, The Netherlands
Manuscript: Relationship Between Clinical Features and Inflammation Related Monocyte Gene Expression in Bipolar Disorder - Towards a Better Understanding of Psychoimmunological Interactions

Janardhanan C. Narayanaswamy, MD, Assistant Professor at the Department of Psychiatry at NIMHANS, Bangalore, India
Manuscript: A Study of Emotion Processing Strategies in Bipolar Disorder: Novel Evidence for the Endophenotype Status of Labeling Deficit

Samuel Sarrazin, MSc, Resident in Psychiatry, St. Anne Hospital, Paris, France
Manuscript: A Multicenter Tractography Study of White Matter Integrity in Bipolar Disorder and Effects of Psychotic Features

Samira S. Valvassori, MSc, Department of Psychiatry, University of Toronto, Toronto, Canada
Manuscript: Effects of Mood Stabilizers on the Signaling Pathways that Mediate Cell Death in an Animal Model of Mania induced by Ouabain

 

2012

 

Rasim Diler, MD, Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
Manuscript: Neural Activity During Emotion Processing in Bipolar versus Unipolar Depression in Adolescents

Jan-Marie Kozicky, BSc Honors, Graduate Program in Neuroscience, University of British Columbia, Vancouver, British Columbia, Canada
Manuscript: Executive function deficits and morphological brain changes in patients with bipolar I disorder following recovery from a first manic episode

Pedro Vieira da Silva Magalhães, MD, PhD, Post-doctoral Research Fellowship, National Institute for Translational Medicine, Hospital de Clínicas de Porto Alegre, RS, Brazil 
Manuscript: A nested population-based case-control study on peripheral inflammation markers and brain-derived neurotrophic factor in early-stage mood disorders

Cristian Zeni, MD, MSc, Department of Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
Manuscript: BDNF in Juvenile Bipolar Disorder and ADHD: differentiation using BDNFserum levels, and Val66Met Polymorphism

 

2011

 

Jigar Jogia, PhD, Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, United Kingdom, for his manuscript: Frontopolar Cortical Inefficiency Underpins Reward and Working Memory Dysfunction in Bipolar Disorder

Robin Nusslock, PhD, Department of Psychology, Northwestern University, Evanstown, Illinois, United States, for his manuscript: Waiting to win: Elevated striatal and orbitofrontal cortical activity during reward anticipation in euthymic bipolar adults

Guillermo Pérez Algorta, PhD, Department of Psychology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States, for his manuscript: An Inexpensive Family Index of Risk for Mood Issues Improves Identification of Pediatric Bipolar Disorder

Naren Rao, MD, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India, for his manuscript: Antithetical Relative Emotional Interference in Bipolar Disorder And Schizophrenia: An Optimized Emotional Stroop Study

2010

 

Brisa Fernandes, MD, MSc, Federal University of Rio Grande do Sul, Porto Alegre, Brazil, for her manuscript: Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis

Mauricio Kunz, MD, University of British Columbia, Vancouver, Canada, for his manuscript:Brain-derived neurotrophic factor and inflammatory markers as predictors of outcome in bipolar disorder: prospective data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM)

Adriene Rosa, PhD, Bipolar Disorders Program, Clinic Hospital of Barcelona, Barcelona, Spain, for her manuscript: Functional Impairment and Disability across Mood States in Bipolar Disorder

Vesile Senturk, MD, MSc, Department of Psychiatry, Ankara University School of Medicine, Ankara, Turkey, for her manuscript: Cognitive profile of euthymic patients with bipolar disorder on monotherapy with novel antipsychotics or mood stabilizers

 

2009

 

Ana Andreazza, PhD, Department of Psychiatry, University of British Columbia, Vancouver, Canada, for her manuscript: Decreased Complex I Activity and Increased Oxidative-Modified Protein in the Postmortem Prefrontal Cortex of Subjects with Bipolar Disorder

David Bond, MD, Department of Psychiatry, University of British Columbia, Vancouver, Canada, for his manuscript: The Association of Weight Gain with Mood Symptoms and Functional Outcomes in First-Episode Mania Patients: Prospective 12-Month Data from the Systematic Treatment Optimization Program for Early Mania

Seetal Dodd, PhD, Department of Clinical and Biomedical Sciences: Barwon Health, University of Melbourne, Australia, for his manuscript: A Prospective Study of the Impact of Subthreshold Mixed States on the 24-Month Clinical Outcomes of Bipolar I Disorder or Schizoaffective Disorder

Sandip Kulkarni, MD, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India, for his manuscript: Impairment of Verbal Learning and Memory and Executive Function in Unaffected Siblings of Probands with Familial Bipolar Disorder

Fernando Neves , MD, PhD, Grupo de Estudos em Neuropsiquiatria Clínica e Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, for his manuscript: Is the Serotonin Transporter Polymorphism (5-HTTLPR) a Potential Marker for Suicidal Behavior in Bipolar Disorder Patients?

2008

 

Dr. Benjamin I. Goldstein MD, from the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. His innovative work focused on substance use disorders among adolescents with bipolar spectrum disorders.

Dr. Morgan Haldane, MB, BS, BSc, MRCPsych, Section of Neurobiology of Psychosis, Institute of Psychiatry, London, United Kingdom, for his research on the impact of COMT VAL158MET genotype on neural correlates of facial affect recognition in bipolar disorder patients and unaffected siblings.

Dr. Carlos Lopez, MD, MSc, from the Department of Psychiatry, School of Medicine, Universidad De Antioquia, Medellin, Colombia, for his work entitled ‘Effect of chronicity on the cognitive performance of patients with bipolar disorder type 1’.

Dr. Samir Kumar Praharaj, MBBS, MD, DPM, from the Central Institute of Psychiatry, Kanke, Ranchi, Jharkhand, India, who explored cerebral blood flow changes and efficacy of rapid suprathreshold repetitive trans-cranial magnetic stimulation of right prefrontal cortex in bipolar mania.

 

2006

 

Dr. Carrie Bearden, PhD - University of California, Los Angeles - Los Angeles, CA, USA
Manuscript: Evidence for Disruption in Prefrontal Cortical Functions in Juvenile Bipolar Disorder

Dr. Marcia Kauer-Sant’Anna, MD - University of British Columbia - Vancouver, BC, Canada
Manuscript: Traumatic Life Events in Bipolar Disorder: Impact on BDNF Levels and Psychopathology

Dr. Benicio Frey, MD, MSc - Federal University of Rio Grande do Sul - Porto Alegre, RS, Brazil
Manuscript: Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study

Dr. Vesile Senturk, MD - Ankara University Psychiatry Dikimevi - Ankara, Turkey
Manuscript: Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate